hydroxyurea has been researched along with Bright Disease in 3 studies
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aygun, B | 1 |
Mortier, NA | 1 |
Smeltzer, MP | 1 |
Shulkin, BL | 1 |
Hankins, JS | 1 |
Ware, RE | 1 |
Au, WY | 1 |
Hung, KN | 1 |
Loong, F | 1 |
Ma, SK | 1 |
Ford-Hutchinson, AW | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease[NCT00305175] | 260 participants (Actual) | Observational | 2006-03-03 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for hydroxyurea and Bright Disease
Article | Year |
---|---|
Leukotriene antagonists and inhibitors: clinical applications.
Topics: Animals; Asthma; Glomerulonephritis; Humans; Hydroxyurea; Indoles; Inflammatory Bowel Diseases; Leuk | 1995 |
1 trial available for hydroxyurea and Bright Disease
Article | Year |
---|---|
Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.
Topics: Adolescent; Albuminuria; Anemia, Sickle Cell; Antisickling Agents; Child; Child, Preschool; Cohort S | 2013 |
1 other study available for hydroxyurea and Bright Disease
Article | Year |
---|---|
Patients presenting with CNS lesions. Case 3. Sequential myeloproliferative disease and glioblastoma multiforme in a renal transplant recipient.
Topics: Administration, Oral; Brain Neoplasms; Chronic Disease; Diagnosis, Differential; Female; Frontal Lob | 2003 |